Conflict of interest: D.K. has consulted for and received research funding from Amgen, GlaxoSmithKline, Pfizer, Shionogi, ONO, 3SBios, Eisai. A.M. is a consultant for Amgen. A.L. was an employee of and is a stockholder for Amgen. Medical writing assistance provided by Susanna Mac of Amgen.
TPO concentrations and response to romiplostim
Article first published online: 27 AUG 2014
© 2014 Wiley Periodicals, Inc.
American Journal of Hematology
Volume 89, Issue 12, pages 1155–1156, December 2014
How to Cite
Kuter, D. J., Meibohm, A. and Lopez, A. (2014), TPO concentrations and response to romiplostim. Am. J. Hematol., 89: 1155–1156. doi: 10.1002/ajh.23818
- Issue published online: 19 NOV 2014
- Article first published online: 27 AUG 2014
- Accepted manuscript online: 31 JUL 2014 08:50AM EST
- Manuscript Accepted: 29 JUL 2014
- Manuscript Received: 28 JUL 2014